Short Interest in iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Rises By 268.9%

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) was the recipient of a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 11,695 shares, a growth of 268.9% from the January 15th total of 3,170 shares. Based on an average trading volume of 15,962 shares, the short-interest ratio is presently 0.7 days. Approximately 0.7% of the shares of the company are short sold. Approximately 0.7% of the shares of the company are short sold. Based on an average trading volume of 15,962 shares, the short-interest ratio is presently 0.7 days.

iShares LifePath Target Date 2045 ETF Trading Up 0.2%

Shares of NYSEARCA:ITDE traded up $0.08 during mid-day trading on Wednesday, reaching $37.86. The company had a trading volume of 8,080 shares, compared to its average volume of 16,596. iShares LifePath Target Date 2045 ETF has a one year low of $27.42 and a one year high of $37.93. The company’s 50-day moving average price is $36.87 and its 200-day moving average price is $36.01. The firm has a market cap of $59.06 million, a price-to-earnings ratio of 20.03 and a beta of 0.82.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. Susquehanna International Group LLP grew its stake in shares of iShares LifePath Target Date 2045 ETF by 38.4% during the 3rd quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock worth $323,000 after acquiring an additional 2,496 shares during the period. Sunbelt Securities Inc. raised its stake in iShares LifePath Target Date 2045 ETF by 2,054.5% in the 3rd quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock valued at $94,000 after acquiring an additional 2,486 shares during the period. Capital Advisors Ltd. LLC purchased a new stake in iShares LifePath Target Date 2045 ETF during the fourth quarter valued at about $53,000. Finally, Geneos Wealth Management Inc. purchased a new stake in iShares LifePath Target Date 2045 ETF during the first quarter valued at about $34,000.

iShares LifePath Target Date 2045 ETF Company Profile

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.